Tang et al. [30] in their recent study, investigated the effects of thrombin and/or its receptor, protease-activated receptor 1 (PAR-1) on both NLRP3 inflammasome and NF-κB signalling in DN patients, as well as their molecular mechanism. The gene discussed is NLRP3; the disease is liver dysplastic nodule.